Number of the records: 1
modelovanie molekulovej štruktúry liekov
SYS d015195 LBL 00000cz--a2200000n--4500 005 20250606214153.9 008 920421|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 $d BA006 065 $a E05.290.563.250 066 $a 01 $c 03 150 $a modelovanie molekulovej štruktúry liekov $x CL $x EC $x ES $x HI $x IS $x MT $x SN $x ST $x TD $x VE $2 slo 450 $w v $a Computer-Aided Drug Design $2 eng 450 $w v $a Computerized Drug Design $2 eng 450 $w v $a Drug Modeling $2 eng 450 $w v $a Pharmaceutical Design $2 eng 450 $w v $a projektovanie liečiv, počítačovo podporované $2 slo 450 $w v $a návrh liečiv, počítačový $2 slo 450 $w v $a dizajn liekov, počítačový $2 slo 450 $w v $a modelovanie liekov $2 slo 450 $w v $a dizajn farmaceutický $2 alo 450 $w v $a design farmaceutický $2 slo 550 $7 sllk_us_auth*d015198 $Y Designer Drugs $w p $a drogy dizajnérske 550 $7 sllk_us_auth*d017076 $Y Computer-Aided Design $w p $a dizajn riadený počítačom 665 $a 89 $2 eng 665 $a Chemistry, Pharmaceutical (1966-1988) $2 eng 665 $a Drugs (1966-1988) $2 eng 680 9-
$i The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. $2 eng 680 $a do not confuse with DESIGNER DRUGS $2 eng 750 -2
$a Drug Design $2 eng 980 $x M
Number of the records: 1